Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection
Abstract Background Chronic hepatitis B virus (HBV) infection increases the risk of liver injury in patients who undergo antituberculosis treatment. It is uncertain whether antiviral treatment for HBV at the time of tuberculosis diagnosis would reduce the risk of liver injury. Methods We performed a...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2020-02, Vol.70 (4), p.660-666 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 666 |
|---|---|
| container_issue | 4 |
| container_start_page | 660 |
| container_title | Clinical infectious diseases |
| container_volume | 70 |
| creator | Lui, Grace C Y Wong, Ngai-Sze Wong, Rity Y K Tse, Yee-Kit Wong, Vincent W S Leung, Chi-Chiu Chan, Henry L Y Wong, Grace L H |
| description | Abstract
Background
Chronic hepatitis B virus (HBV) infection increases the risk of liver injury in patients who undergo antituberculosis treatment. It is uncertain whether antiviral treatment for HBV at the time of tuberculosis diagnosis would reduce the risk of liver injury.
Methods
We performed a population-level, retrospective, cohort study that involved all patients with tuberculosis–HBV coinfection treated in public hospitals in Hong Kong over a 16-year period. Patients who received antiviral treatment at the time of tuberculosis diagnosis were considered “patients on antiviral therapy.” A multivariable Cox proportional hazards model was used to determine the adjusted hazard ratio of hospitalization due to drug-induced liver injury within 1 year in patients on antiviral therapy, adjusting for the propensity score.
Results
Of 3698 patients with tuberculosis–HBV coinfection, 488 (13.2%) were patients on antiviral therapy. Of the remaining 3210 patients, 446 (13.9%) started antiviral therapy within 1 year of tuberculosis diagnosis. Adjusting for the propensity score, patients on antiviral therapy had a lower risk of hospitalization due to drug-induced liver injury compared with those not on treatment (adjusted hazard ratio, 0.44; 95% confidence interval .26–.72). Compared with patients who started antiviral therapy within 1 year of tuberculosis diagnosis, patients on antiviral therapy also had a lower risk of hospitalization due to drug-induced liver injury and a lower risk of liver-related mortality.
Conclusions
We show that antiviral treatment for HBV given at the time of tuberculosis diagnosis reduced the risk of liver injury in tuberculosis–HBV coinfected patients.
In a population-level, retrospective cohort of 3698 patients with tuberculosis and hepatitis B coinfection, antiviral treatment for hepatitis B at the time of diagnosis of tuberculosis reduced hospitalization due to drug-induced liver injury by 56%, adjusting for the propensity score. |
| doi_str_mv | 10.1093/cid/ciz241 |
| format | Article |
| fullrecord | <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_cid_ciz241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cid/ciz241</oup_id><sourcerecordid>10.1093/cid/ciz241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-c780e9aaf24776a75a1e8cb303a6adf9366213181a76192d77c840774a6779f93</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlYv_gDJxYuwmtns5uNYi9pCwR4qHpc0m6Up7e6aZAv11xtdFbx4GGbgfeY9PAhdArkFIumdtmWc9zSDIzSEnPKE5RKO401ykWSCigE6835DCIAg-SkaUCJBCpEN0du4DnZvndri5do41R5w1Tg8Na0KNliP7_HCmb2pg8dzuzcOz-pN5w7Y1ngRka_g1YY1XnYr43S3bXz8UnX5p2PS2LoyOtimPkcnldp6c_G9R-jl8WE5mSbz56fZZDxPNAUeEs0FMVKpKs04Z4rnCozQK0qoYqqsJGUsBQoCFGcg05JzLTLCeaYY5zLmI3TT92rXeO9MVbTO7pQ7FECKT29F9Fb03iJ81cNtt9qZ8hf9ERWB6x5ouva_og-spXbq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Lui, Grace C Y ; Wong, Ngai-Sze ; Wong, Rity Y K ; Tse, Yee-Kit ; Wong, Vincent W S ; Leung, Chi-Chiu ; Chan, Henry L Y ; Wong, Grace L H</creator><creatorcontrib>Lui, Grace C Y ; Wong, Ngai-Sze ; Wong, Rity Y K ; Tse, Yee-Kit ; Wong, Vincent W S ; Leung, Chi-Chiu ; Chan, Henry L Y ; Wong, Grace L H</creatorcontrib><description>Abstract
Background
Chronic hepatitis B virus (HBV) infection increases the risk of liver injury in patients who undergo antituberculosis treatment. It is uncertain whether antiviral treatment for HBV at the time of tuberculosis diagnosis would reduce the risk of liver injury.
Methods
We performed a population-level, retrospective, cohort study that involved all patients with tuberculosis–HBV coinfection treated in public hospitals in Hong Kong over a 16-year period. Patients who received antiviral treatment at the time of tuberculosis diagnosis were considered “patients on antiviral therapy.” A multivariable Cox proportional hazards model was used to determine the adjusted hazard ratio of hospitalization due to drug-induced liver injury within 1 year in patients on antiviral therapy, adjusting for the propensity score.
Results
Of 3698 patients with tuberculosis–HBV coinfection, 488 (13.2%) were patients on antiviral therapy. Of the remaining 3210 patients, 446 (13.9%) started antiviral therapy within 1 year of tuberculosis diagnosis. Adjusting for the propensity score, patients on antiviral therapy had a lower risk of hospitalization due to drug-induced liver injury compared with those not on treatment (adjusted hazard ratio, 0.44; 95% confidence interval .26–.72). Compared with patients who started antiviral therapy within 1 year of tuberculosis diagnosis, patients on antiviral therapy also had a lower risk of hospitalization due to drug-induced liver injury and a lower risk of liver-related mortality.
Conclusions
We show that antiviral treatment for HBV given at the time of tuberculosis diagnosis reduced the risk of liver injury in tuberculosis–HBV coinfected patients.
In a population-level, retrospective cohort of 3698 patients with tuberculosis and hepatitis B coinfection, antiviral treatment for hepatitis B at the time of diagnosis of tuberculosis reduced hospitalization due to drug-induced liver injury by 56%, adjusting for the propensity score.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciz241</identifier><identifier>PMID: 30919884</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Antiviral Agents - adverse effects ; Cohort Studies ; Coinfection - drug therapy ; Hepatitis B - complications ; Hepatitis B - drug therapy ; Hepatitis B virus ; Hepatitis B, Chronic - complications ; Hepatitis B, Chronic - drug therapy ; Hong Kong - epidemiology ; Humans ; Retrospective Studies ; Tuberculosis - complications ; Tuberculosis - drug therapy ; Tuberculosis - prevention & control</subject><ispartof>Clinical infectious diseases, 2020-02, Vol.70 (4), p.660-666</ispartof><rights>The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2019</rights><rights>The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c317t-c780e9aaf24776a75a1e8cb303a6adf9366213181a76192d77c840774a6779f93</citedby><cites>FETCH-LOGICAL-c317t-c780e9aaf24776a75a1e8cb303a6adf9366213181a76192d77c840774a6779f93</cites><orcidid>0000-0002-2863-9389 ; 0000-0001-5242-2967</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30919884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lui, Grace C Y</creatorcontrib><creatorcontrib>Wong, Ngai-Sze</creatorcontrib><creatorcontrib>Wong, Rity Y K</creatorcontrib><creatorcontrib>Tse, Yee-Kit</creatorcontrib><creatorcontrib>Wong, Vincent W S</creatorcontrib><creatorcontrib>Leung, Chi-Chiu</creatorcontrib><creatorcontrib>Chan, Henry L Y</creatorcontrib><creatorcontrib>Wong, Grace L H</creatorcontrib><title>Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Abstract
Background
Chronic hepatitis B virus (HBV) infection increases the risk of liver injury in patients who undergo antituberculosis treatment. It is uncertain whether antiviral treatment for HBV at the time of tuberculosis diagnosis would reduce the risk of liver injury.
Methods
We performed a population-level, retrospective, cohort study that involved all patients with tuberculosis–HBV coinfection treated in public hospitals in Hong Kong over a 16-year period. Patients who received antiviral treatment at the time of tuberculosis diagnosis were considered “patients on antiviral therapy.” A multivariable Cox proportional hazards model was used to determine the adjusted hazard ratio of hospitalization due to drug-induced liver injury within 1 year in patients on antiviral therapy, adjusting for the propensity score.
Results
Of 3698 patients with tuberculosis–HBV coinfection, 488 (13.2%) were patients on antiviral therapy. Of the remaining 3210 patients, 446 (13.9%) started antiviral therapy within 1 year of tuberculosis diagnosis. Adjusting for the propensity score, patients on antiviral therapy had a lower risk of hospitalization due to drug-induced liver injury compared with those not on treatment (adjusted hazard ratio, 0.44; 95% confidence interval .26–.72). Compared with patients who started antiviral therapy within 1 year of tuberculosis diagnosis, patients on antiviral therapy also had a lower risk of hospitalization due to drug-induced liver injury and a lower risk of liver-related mortality.
Conclusions
We show that antiviral treatment for HBV given at the time of tuberculosis diagnosis reduced the risk of liver injury in tuberculosis–HBV coinfected patients.
In a population-level, retrospective cohort of 3698 patients with tuberculosis and hepatitis B coinfection, antiviral treatment for hepatitis B at the time of diagnosis of tuberculosis reduced hospitalization due to drug-induced liver injury by 56%, adjusting for the propensity score.</description><subject>Antiviral Agents - adverse effects</subject><subject>Cohort Studies</subject><subject>Coinfection - drug therapy</subject><subject>Hepatitis B - complications</subject><subject>Hepatitis B - drug therapy</subject><subject>Hepatitis B virus</subject><subject>Hepatitis B, Chronic - complications</subject><subject>Hepatitis B, Chronic - drug therapy</subject><subject>Hong Kong - epidemiology</subject><subject>Humans</subject><subject>Retrospective Studies</subject><subject>Tuberculosis - complications</subject><subject>Tuberculosis - drug therapy</subject><subject>Tuberculosis - prevention & control</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlYv_gDJxYuwmtns5uNYi9pCwR4qHpc0m6Up7e6aZAv11xtdFbx4GGbgfeY9PAhdArkFIumdtmWc9zSDIzSEnPKE5RKO401ykWSCigE6835DCIAg-SkaUCJBCpEN0du4DnZvndri5do41R5w1Tg8Na0KNliP7_HCmb2pg8dzuzcOz-pN5w7Y1ngRka_g1YY1XnYr43S3bXz8UnX5p2PS2LoyOtimPkcnldp6c_G9R-jl8WE5mSbz56fZZDxPNAUeEs0FMVKpKs04Z4rnCozQK0qoYqqsJGUsBQoCFGcg05JzLTLCeaYY5zLmI3TT92rXeO9MVbTO7pQ7FECKT29F9Fb03iJ81cNtt9qZ8hf9ERWB6x5ouva_og-spXbq</recordid><startdate>20200203</startdate><enddate>20200203</enddate><creator>Lui, Grace C Y</creator><creator>Wong, Ngai-Sze</creator><creator>Wong, Rity Y K</creator><creator>Tse, Yee-Kit</creator><creator>Wong, Vincent W S</creator><creator>Leung, Chi-Chiu</creator><creator>Chan, Henry L Y</creator><creator>Wong, Grace L H</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-2863-9389</orcidid><orcidid>https://orcid.org/0000-0001-5242-2967</orcidid></search><sort><creationdate>20200203</creationdate><title>Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection</title><author>Lui, Grace C Y ; Wong, Ngai-Sze ; Wong, Rity Y K ; Tse, Yee-Kit ; Wong, Vincent W S ; Leung, Chi-Chiu ; Chan, Henry L Y ; Wong, Grace L H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-c780e9aaf24776a75a1e8cb303a6adf9366213181a76192d77c840774a6779f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antiviral Agents - adverse effects</topic><topic>Cohort Studies</topic><topic>Coinfection - drug therapy</topic><topic>Hepatitis B - complications</topic><topic>Hepatitis B - drug therapy</topic><topic>Hepatitis B virus</topic><topic>Hepatitis B, Chronic - complications</topic><topic>Hepatitis B, Chronic - drug therapy</topic><topic>Hong Kong - epidemiology</topic><topic>Humans</topic><topic>Retrospective Studies</topic><topic>Tuberculosis - complications</topic><topic>Tuberculosis - drug therapy</topic><topic>Tuberculosis - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lui, Grace C Y</creatorcontrib><creatorcontrib>Wong, Ngai-Sze</creatorcontrib><creatorcontrib>Wong, Rity Y K</creatorcontrib><creatorcontrib>Tse, Yee-Kit</creatorcontrib><creatorcontrib>Wong, Vincent W S</creatorcontrib><creatorcontrib>Leung, Chi-Chiu</creatorcontrib><creatorcontrib>Chan, Henry L Y</creatorcontrib><creatorcontrib>Wong, Grace L H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lui, Grace C Y</au><au>Wong, Ngai-Sze</au><au>Wong, Rity Y K</au><au>Tse, Yee-Kit</au><au>Wong, Vincent W S</au><au>Leung, Chi-Chiu</au><au>Chan, Henry L Y</au><au>Wong, Grace L H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2020-02-03</date><risdate>2020</risdate><volume>70</volume><issue>4</issue><spage>660</spage><epage>666</epage><pages>660-666</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Abstract
Background
Chronic hepatitis B virus (HBV) infection increases the risk of liver injury in patients who undergo antituberculosis treatment. It is uncertain whether antiviral treatment for HBV at the time of tuberculosis diagnosis would reduce the risk of liver injury.
Methods
We performed a population-level, retrospective, cohort study that involved all patients with tuberculosis–HBV coinfection treated in public hospitals in Hong Kong over a 16-year period. Patients who received antiviral treatment at the time of tuberculosis diagnosis were considered “patients on antiviral therapy.” A multivariable Cox proportional hazards model was used to determine the adjusted hazard ratio of hospitalization due to drug-induced liver injury within 1 year in patients on antiviral therapy, adjusting for the propensity score.
Results
Of 3698 patients with tuberculosis–HBV coinfection, 488 (13.2%) were patients on antiviral therapy. Of the remaining 3210 patients, 446 (13.9%) started antiviral therapy within 1 year of tuberculosis diagnosis. Adjusting for the propensity score, patients on antiviral therapy had a lower risk of hospitalization due to drug-induced liver injury compared with those not on treatment (adjusted hazard ratio, 0.44; 95% confidence interval .26–.72). Compared with patients who started antiviral therapy within 1 year of tuberculosis diagnosis, patients on antiviral therapy also had a lower risk of hospitalization due to drug-induced liver injury and a lower risk of liver-related mortality.
Conclusions
We show that antiviral treatment for HBV given at the time of tuberculosis diagnosis reduced the risk of liver injury in tuberculosis–HBV coinfected patients.
In a population-level, retrospective cohort of 3698 patients with tuberculosis and hepatitis B coinfection, antiviral treatment for hepatitis B at the time of diagnosis of tuberculosis reduced hospitalization due to drug-induced liver injury by 56%, adjusting for the propensity score.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>30919884</pmid><doi>10.1093/cid/ciz241</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2863-9389</orcidid><orcidid>https://orcid.org/0000-0001-5242-2967</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2020-02, Vol.70 (4), p.660-666 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_cid_ciz241 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Antiviral Agents - adverse effects Cohort Studies Coinfection - drug therapy Hepatitis B - complications Hepatitis B - drug therapy Hepatitis B virus Hepatitis B, Chronic - complications Hepatitis B, Chronic - drug therapy Hong Kong - epidemiology Humans Retrospective Studies Tuberculosis - complications Tuberculosis - drug therapy Tuberculosis - prevention & control |
| title | Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A27%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antiviral%20Therapy%20for%20Hepatitis%20B%20Prevents%20Liver%20Injury%20in%20Patients%20With%20Tuberculosis%20and%20Hepatitis%20B%20Coinfection&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Lui,%20Grace%20C%20Y&rft.date=2020-02-03&rft.volume=70&rft.issue=4&rft.spage=660&rft.epage=666&rft.pages=660-666&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciz241&rft_dat=%3Coup_cross%3E10.1093/cid/ciz241%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30919884&rft_oup_id=10.1093/cid/ciz241&rfr_iscdi=true |